17,810 Shares in Sotera Health Company $SHC Purchased by Aristeia Capital L.L.C.

Key Points

• Aristeia Capital has invested $208,000 in **Sotera Health Company**, acquiring 17,810 shares during the first quarter, highlighting institutional interest in the stock.
• Sotera Health reported a quarterly **EPS of $0.20**, beating estimates, with revenue of **$294.34 million**, showcasing a 6.4% increase year-over-year.
• Equities research analysts have published a consensus rating of **"Moderate Buy"** for Sotera Health, with a price target of **$16.00** and four analysts recommending a Buy rating.

Aristeia Capital L.L.C. purchased a new position in shares of Sotera Health Company (NASDAQ:SHC - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 17,810 shares of the company's stock, valued at approximately $208,000.

Several other institutional investors also recently bought and sold shares of the business. The Manufacturers Life Insurance Company raised its stake in shares of Sotera Health by 2.9% during the 4th quarter. The Manufacturers Life Insurance Company now owns 131,889 shares of the company's stock worth $1,804,000 after buying an additional 3,667 shares during the period. Northern Trust Corp increased its holdings in Sotera Health by 23.6% in the 4th quarter. Northern Trust Corp now owns 1,334,367 shares of the company's stock worth $18,254,000 after acquiring an additional 254,768 shares in the last quarter. Ananym Capital Management LP acquired a new position in Sotera Health during the fourth quarter worth $13,680,000. BNP Paribas Financial Markets acquired a new position in Sotera Health during the fourth quarter worth $208,000. Finally, Nomura Holdings Inc. purchased a new position in Sotera Health during the fourth quarter valued at $278,000. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Price Performance

SHC stock traded down $0.07 during midday trading on Friday, reaching $16.05. The stock had a trading volume of 2,486,837 shares, compared to its average volume of 1,379,324. The company's fifty day simple moving average is $13.69 and its 200 day simple moving average is $12.42. The company has a current ratio of 2.47, a quick ratio of 2.23 and a debt-to-equity ratio of 4.49. The company has a market cap of $4.56 billion, a price-to-earnings ratio of 200.65 and a beta of 1.84. Sotera Health Company has a 52-week low of $9.53 and a 52-week high of $16.99.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The business had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. During the same period last year, the company earned $0.19 EPS. The company's revenue for the quarter was up 6.4% on a year-over-year basis. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, sell-side analysts predict that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Wall Street Zen raised shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Barclays reiterated an "overweight" rating on shares of Sotera Health in a research note on Friday, August 8th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $16.00.

Insiders Place Their Bets

In other Sotera Health news, insider Michael P. Rutz sold 126,611 shares of the firm's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $16.38, for a total value of $2,073,888.18. Following the completion of the sale, the insider directly owned 450,204 shares of the company's stock, valued at $7,374,341.52. This trade represents a 21.95% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gtcr Investment Xi Llc sold 8,000,000 shares of the firm's stock in a transaction on Friday, September 5th. The stock was sold at an average price of $15.11, for a total value of $120,880,000.00. Following the completion of the sale, the director directly owned 41,215,301 shares of the company's stock, valued at $622,763,198.11. This trade represents a 16.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 20,126,611 shares of company stock valued at $304,273,888 in the last three months. 47.55% of the stock is currently owned by insiders.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.